Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial. — المؤلف: Azoulay, Elie — JAMA 20181228
- المؤلف
- Azoulay, Elie
- النشر
- JAMA 20181228
- الوصف
- 2099-2107 p.
- الموضوعات
- Adult؛ Aged؛ Critical Illness؛ Female؛ High-Frequency Ventilation؛ Humans؛ Immunocompromised Host؛ Male